Home > Insider Trading > Filing (0001104659-23-055648)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1657312	Verona Pharma Plc	VRNA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1836883	A. Kathleen Rickard	3 More London Riverside London X0 SE1 2RE	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2023-05-01	77,424	$2.58	2,999,888	No	4	S	Direct
Ordinary Shares	Disposition	2023-05-03	28,752	$2.65	2,971,136	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
These sales were effected pursuant to a Rule 10b5-1 instruction entered into on May 14, 2021 solely with the intent to cover taxes in connection with the vesting of certainly previously reported Restricted Share Units.
The price reported represents the sale price of the ADSs divided by eight (8).
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023.
The price reported represents a weighted average sale price of the ADSs divided by eight (8). These shares were sold in multiple transactions at prices ranging from $2.6138 to $2.6763, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Consists of (i) 1,743,488 Ordinary Shares underlying RSUs (which are represented by 217,936 ADSs); and (ii) 1,227,648 Ordinary Shares underlying 153,456 ADSs.